XML 31 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Details) (USD $)
0 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended
Nov. 13, 2013
Jun. 10, 2013
Sep. 30, 2013
Jun. 30, 2013
Nov. 30, 2013
Nov. 30, 2012
Nov. 30, 2013
Nov. 30, 2012
Dec. 31, 2013
Subsequent Event [Member]
Nov. 30, 2013
Marketing And Distribution Rights [Member]
Nov. 30, 2013
Purchased Technology Use Rightsand Licenses [Member]
Nov. 30, 2013
Patents [Member]
Sep. 30, 2013
Minimum [Member]
Nov. 30, 2013
Minimum [Member]
Sep. 30, 2013
Maximum [Member]
Nov. 30, 2013
Maximum [Member]
Significant Accounting Policies (Details) [Line Items]                                
Property, Plant and Equipment, Useful Life                           5 years   10 years
Depreciation, Depletion and Amortization (in Dollars)         $ 43,452 $ 65,435 $ 86,231 $ 93,263                
Finite-Lived Intangible Asset, Useful Life                   18 years 10 years 17 years        
Amortization of Intangible Assets (in Dollars)         3,665 8,779 11,121 17,559                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares) 32,000 20,000         52,000                  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.84 $ 0.83         $ 0.84                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)     2,500 2,000     4,500   12,000              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)       $ 0.38     $ 0.40   $ 0.38       $ 0.38   $ 0.45  
Proceeds from Stock Options Exercised (in Dollars)       760     1,780 5,999                
Equity Method Investment, Ownership Percentage         6.00%   6.00%                  
Deferred Tax Assets, Valuation Allowance (in Dollars)         $ 0   $ 0                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)         372,816   379,180